Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial

[1]  S. Kesler,et al.  Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial , 2018, Supportive Care in Cancer.

[2]  J. McQuade,et al.  Randomized controlled trial of neurofeedback on chemotherapy‐induced peripheral neuropathy: A pilot study , 2017, Cancer.

[3]  C. Loprinzi,et al.  Chemotherapy‐induced neuropathy: Central resolution of a peripherally perceived problem? , 2017, Cancer.

[4]  Thomas J. Smith,et al.  Treatment of human immunodeficiency virus-related peripheral neuropathy with Scrambler Therapy: a case report , 2017, International journal of STD & AIDS.

[5]  S. Sagar,et al.  Phase 2 Study of Acupuncture-Like Transcutaneous Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy , 2016, Integrative cancer therapies.

[6]  Thomas J. Smith,et al.  Scrambler Therapy for the management of chronic pain , 2016, Supportive Care in Cancer.

[7]  Yong-Chul Kim,et al.  An exploratory study on the effectiveness of "Calmare therapy" in patients with cancer-related neuropathic pain: A pilot study. , 2016, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[8]  P. Notaro,et al.  Pilot evaluation of scrambler therapy for pain induced by bone and visceral metastases and refractory to standard therapies , 2016, Supportive Care in Cancer.

[9]  C. Loprinzi,et al.  Can pregabalin prevent paclitaxel-associated neuropathy?—An ACCRU pilot trial , 2016, Supportive Care in Cancer.

[10]  C. Compagnone,et al.  Chronic pain treatment and scrambler therapy: a multicenter retrospective analysis. , 2015, Acta bio-medica : Atenei Parmensis.

[11]  Steven P. Cohen,et al.  Predictive Factors Associated With Success and Failure for Calmare (Scrambler) Therapy: A Multicenter Analysis , 2015, The Clinical journal of pain.

[12]  A. Starkweather,et al.  Decreased low back pain intensity and differential gene expression following Calmare®: results from a double-blinded randomized sham-controlled study. , 2015, Research in nursing & health.

[13]  Dawn L Hershman,et al.  Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Thomas J. Smith,et al.  A Trial of Scrambler Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy , 2013, Journal of pain & palliative care pharmacotherapy.

[15]  J. Eickhoff,et al.  A randomized, double-blind study of “Scrambler” therapy versus sham for painful chemotherapy-induced peripheral neuropathy (CIPN). , 2013 .

[16]  C. Shapiro,et al.  Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. , 2013, JAMA.

[17]  N. Aaronson,et al.  Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire , 2013, Quality of Life Research.

[18]  Y. Ko,et al.  Clinical Experiences on the Effect of Scrambler Therapy for Patients with Postherpetic Neuralgia , 2013, The Korean journal of pain.

[19]  J. Moon,et al.  Scrambler Therapy for Patients with Cancer Pain - Case Series - , 2013, The Korean journal of pain.

[20]  Thomas J. Smith,et al.  Treatment of Postherpetic Pain With Scrambler Therapy, a Patient-Specific Neurocutaneous Electrical Stimulation Device , 2012, The American journal of hospice & palliative care.

[21]  M. Maltoni,et al.  Managing chronic pain: results from an open-label study using MC5-A Calmare® device , 2012, Supportive Care in Cancer.

[22]  S. Kumar,et al.  Prospective study of application of biological communication (cybernatics) in management of chronic low back pain--a preliminary report. , 2011, Nepal Medical College journal : NMCJ.

[23]  C. Loprinzi,et al.  A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA , 2011, Supportive Care in Cancer.

[24]  Thomas J. Smith,et al.  Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy. , 2010, Journal of Pain and Symptom Management.

[25]  T. Yan,et al.  Effect of transcutaneous electrical nerve stimulation on symptomatic diabetic peripheral neuropathy: a meta-analysis of randomized controlled trials. , 2010, Diabetes research and clinical practice.

[26]  M. Herceg,et al.  Electrotherapy for the treatment of painful diabetic peripheral neuropathy: a review. , 2010, Journal of rehabilitation medicine.

[27]  E. Kalso,et al.  Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms. , 2009, Anticancer research.

[28]  G. Y. Wong,et al.  Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy , 2007, Cancer.

[29]  D. Sargent,et al.  Laparoscopically assisted vs open colectomy for colon cancer: a meta-analysis. , 2007, Archives of surgery.

[30]  K. Hoang-Xuan,et al.  The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. , 2005, European journal of cancer.

[31]  P. Novotny,et al.  Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy , 2002, Pain.

[32]  T. Therneau,et al.  Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[34]  Thomas J. Smith,et al.  Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy , 2014, Supportive Care in Cancer.

[35]  Thomas J. Smith,et al.  Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial. , 2012, Journal of pain and symptom management.

[36]  G. Marineo.  Untreatable pain resulting from abdominal cancer: new hope from biophysics? , 2003, JOP : Journal of the pancreas.